Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    vorinostat and glioma | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Condition: Brain Cancer
Interventions: Drug: Vorinostat;   Drug: Bevacizumab
2 Recruiting MRSI to Predict Response to RT/TMZ ± Vorinostat in GBM
Condition: Glioblastoma Multiforme of Brain
Interventions: Radiation: Standard Radiation Therapy;   Drug: Standard Temozolomide;   Drug: Vorinostat

Indicates status has not been verified in more than two years